サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1452576

欧州の分子診断：2030年までの市場予測 - 地域別分析 - 疾患領域別、技術別、製品・サービス別、エンドユーザー別

Europe Molecular Diagnostics Market Forecast to 2030 - Regional Analysis - by Disease Area, Technology, Product and Services, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 134 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
欧州の分子診断：2030年までの市場予測 - 地域別分析 - 疾患領域別、技術別、製品・サービス別、エンドユーザー別
出版日: 2024年01月04日
発行: The Insight Partners
ページ情報: 英文 134 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の分子診断市場は、2022年の45億9,254万米ドルから2030年には112億2,577万米ドルに成長すると予測されています。2022年から2030年までのCAGRは11.8%と推定されます。

関連疾患の急増が欧州の分子診断市場を活性化

分子診断法は、腫瘍性疾患、感染症、心疾患、免疫系障害など幅広い疾患の検出に使用できます。また、DNAやRNAなどの遺伝物質を用いた遺伝子検査にも使用でき、さまざまな疾患の診断に利用できます。がんは世界的に主要な死因の一つです。がんを早期に発見すれば、患者の死亡を防ぐことができます。UK.GOVが2021年11月22日に発表したデータによると、COVID-19の感染率は人口10万人当たり422.7人でした。このように、対象疾患の有病率の上昇が分子診断市場の成長を促進しています。

欧州の分子診断市場概要

欧州の分子診断市場は、ドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。同地域は世界の分子診断市場で大きなシェアを占めており、2022～2030年には堅調なCAGRを記録すると予測されています。欧州の市場成長は、ライフサイエンス研究の成長と感染症検査への政府投資の増加に起因しています。

慢性閉塞性肺疾患（COPD）、糖尿病、がん、関節炎などの慢性疾患は、放置すると生命を脅かす可能性があります。例えば、慢性リンパ性白血病（CLL）はドイツで最も多い白血病の一種です。Deutsches Arzteblattによると、ドイツにおけるCLLの有病率は10万人当たり6件程度であり、毎年850人近くの女性と1,000人近くの男性がCLLで死亡しています。

欧州の分子診断市場の収益と2030年までの予測（金額）

欧州の分子診断市場のセグメンテーション

欧州の分子診断市場は、疾患領域、技術、製品・サービス、エンドユーザー、国に区分されます。

疾患領域別に見ると、欧州の分子診断市場は感染症、腫瘍、遺伝子検査、心疾患、免疫系疾患、その他に区分されます。感染症分野は2022年に欧州の分子診断市場で最大のシェアを記録しました。

技術別に見ると、欧州の分子診断市場は、ポリメラーゼ連鎖反応（PCR）、in situハイブリダイゼーション、等温核酸増幅技術（INAAT）、DNAシーケンシングおよび次世代シーケンシング（NGS）、DNAマイクロアレイ、その他に区分されます。ポリメラーゼ連鎖反応（PCR）セグメントは、2022年に欧州の分子診断市場最大のシェアを記録しました。ポリメラーゼ連鎖反応（PCR）はさらにRT-PCR、qPCR、マルチプレックスPCR、その他に細分化されます。

製品とサービスに基づいて、欧州の分子診断市場はアッセイとキット、機器、サービスとソフトウェアに区分されます。2022年の欧州の分子診断市場シェアは、アッセイとキット分野が最大でした。

エンドユーザー別では、欧州の分子診断市場は診断ラボ、病院・診療所、研究・学術機関、その他に区分されます。診断ラボ部門は2022年に欧州の分子診断市場で最大のシェアを占めました。

国別では、欧州の分子診断市場はドイツ、英国、フランス、イタリア、スペイン、その他欧州に分類されます。2022年の欧州の分子診断市場はドイツが独占。

Abbott Laboratories、Agilent Technologies Inc、Thermo Fisher Scientific Inc、F. Hoffmann-La Roche Ltd、Qiagen NV、bioMerieux SA、Illumina Inc、Danaher、Siemens Healthineers AG、Novartis AGは、欧州の分子診断市場に参入している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州の分子診断市場情勢

  • 概観
  • PEST分析
    • 欧州PEST分析

第5章 欧州の分子診断市場力学：主要産業力学

  • 主な市場促進要因
    • 新製品の開発とポイントオブケア検査需要の増加
    • 関連疾患の急増
  • 市場抑制要因
    • 分子検査に伴う限界
  • 市場機会
    • 分子診断技術の進歩
  • 今後の動向
    • 個別化医療における分子診断
  • 影響分析

第6章 分子診断市場-欧州市場分析

  • 欧州の分子診断市場収益、2022年～2030年

第7章 欧州の分子診断市場：収益と2030年までの予測 - 疾患領域別

  • 市場収益シェア（%）、2022年および2030年
  • がん領域
  • 感染症
  • 遺伝子検査
  • 心臓疾患
  • 免疫系疾患
  • その他

第8章 欧州の分子診断市場：収益と2030年までの予測 - 技術別

  • 市場収益シェア（%）、2022年および2030年
  • ポリメラーゼ連鎖反応
  • 等温核酸増幅技術（INAAT）
  • DNAシーケンシングと次世代シーケンシング（NGS）
  • DNAマイクロアレイ
  • インサイチュハイブリダイゼーション（ISH）
  • その他

第9章 欧州の分子診断市場：収益と2030年までの予測 - 製品・サービス別

  • 市場収益シェア（%）、2022年および2030年
  • アッセイとキット
  • 機器
  • サービスおよびソフトウェア

第10章 欧州の分子診断市場：収益と2030年までの予測 - エンドユーザー別

  • 市場収益シェア（%）、2022年および2030年
  • 病院および診療所
  • 診断研究所
  • 研究・学術機関
  • その他

第11章 欧州の分子診断市場：国別分析

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州

第12章 欧州の分子診断市場：業界情勢

  • 市場参入企業の成長戦略（%）
  • 有機的展開
  • 無機的開発

第13章 欧州の分子診断市場、主要企業プロファイル

  • Abbott Laboratories
  • Agilent Technologies Inc
  • Thermo Fisher Scientific Inc
  • F. Hoffmann-La Roche Ltd
  • Qiagen NV
  • bioMerieux SA
  • Illumina Inc
  • Danaher
  • Siemens Healthineers AG
  • Novartis AG

第14章 付録

図表

List Of Tables

  • Table 1. Europe Molecular Diagnostics Market Segmentation
  • Table 2. Germany: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Disease Area
  • Table 3. Germany: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 4. Germany: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 5. Germany: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 6. Germany: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 7. UK: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 8. UK: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 9. UK: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 10. UK: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 11. UK: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 12. France: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 13. France: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 14. France: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 15. France: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 16. France: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 17. Italy: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 18. Italy: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 19. Italy: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 20. Italy: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 21. Italy: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 22. Spain: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 23. Spain: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 24. Spain: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 25. Spain: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 26. Spain: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 27. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 28. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 29. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 30. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 31. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 32. Organic Developments Done By Companies
  • Table 33. Inorganic Developments Done By Companies
  • Table 34. Glossary of Terms, Molecular Diagnostics Market

List Of Figures

  • Figure 1. Europe - PEST Analysis
  • Figure 2. Europe Molecular Diagnostics Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. Europe Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
  • Figure 6. Oncology: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Infectious Disease: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Genetic Testing: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Cardiac Diseases: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Immune System Disorders: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Europe Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 13. PCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. RT-PCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. qPCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Multiplex PCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Isothermal Nucleic Acid Amplification Technology (INAAT): Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. DNA Sequencing and Next-Generation Sequencing (NGS): Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. DNA microarrays: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. In-Situ Hybridization (ISH): Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Europe Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • Figure 24. Assays and Kits: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Instruments: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Services and Software: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Europe Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 28. Hospitals and Clinics: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Ambulatory Surgical Centers: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Research and Academic Institutes: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Europe Molecular Diagnostics Market, By country, 2022 ($Mn)
  • Figure 33. Europe Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
  • Figure 34. Germany: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 35. UK: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 36. France: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 37. Italy: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 38. Spain: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 39. Rest of Europe: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 40. Growth Strategies Done by the Companies in the Market (%)
目次
Product Code: TIPRE00026715

The Europe molecular diagnostics market is expected to grow from US$ 4,592.54 million in 2022 to US$ 11,225.77 million by 2030. It is estimated to grow at a CAGR of 11.8% from 2022 to 2030.

Surging Prevalence of Associated Diseases Fuels Europe Molecular Diagnostics Market

Molecular diagnostics procedures can be employed in the detection of a wide range of conditions such as oncologic diseases, infectious diseases, cardiac diseases, and immune system disorders; they can also be used in genetic testing using genetic material such as DNA and RNA for the diagnosis of different diseases. Cancer is one of the leading causes of death worldwide. The early detection of the disease can help prevent death among the patients. According to the data published by the UK.GOV on November 22, 2021, the infection rate of COVID-19 was ~422.7 per 100,000 population. Thus, the rising prevalence of target diseases fuels the molecular diagnostics market growth.

Europe Molecular Diagnostics Market Overview

The European molecular diagnostics market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the global molecular diagnostics market and is expected to register a robust CAGR during 2022-2030. The market growth in Europe is attributed to growing life science research and an increase in government investment in testing infectious diseases.

Chronic diseases such as chronic obstructive pulmonary disease (COPD), diabetes, cancer, and arthritis can be life-threatening if left untreated. For instance, chronic lymphocytic leukemia (CLL) is the most common type of leukemia in Germany. According to the Deutsches Arzteblatt, the prevalence of CLL in Germany stands at ~6 cases per 100,000; nearly 850 women and 1,000 men die from CLL every year.

Europe Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

Europe Molecular Diagnostics Market Segmentation

The Europe molecular diagnostics market is segmented into disease area, technology, product and services, end user, and country.

Based on disease area, the Europe molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment registered the largest Europe molecular diagnostics market share in 2022.

Based on technology, the Europe molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment registered the largest Europe molecular diagnostics market share in 2022. The polymerase chain reaction (PCR) is further sub segmented into RT-PCR, qPCR, multiplex PCR, and others.

Based on product and services, the Europe molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment registered the largest Europe molecular diagnostics market share in 2022.

Based on end users, the Europe molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held the largest Europe molecular diagnostics market share in 2022.

Based on country, the Europe molecular diagnostics market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe molecular diagnostics market in 2022.

Abbott Laboratories, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, bioMerieux SA, Illumina Inc, Danaher, Siemens Healthineers AG, and Novartis AG are some of the leading companies operating in the Europe molecular diagnostics market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Molecular Diagnostics Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Europe PEST Analysis

5. Europe Molecular Diagnostics Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing
    • 5.1.2 Surging Prevalence of Associated Diseases
  • 5.2 Market Restraints
    • 5.2.1 Limitations Associated with Molecular Testing
  • 5.3 Market Opportunities
    • 5.3.1 Advancements in Molecular Diagnostics Technologies
  • 5.4 Future Trends
    • 5.4.1 Molecular Diagnostics in Personalized Medicine
  • 5.5 Impact Analysis:

6. Molecular Diagnostics Market - Europe Market Analysis

  • 6.1 Europe Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030

7. Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Disease Area

  • 7.1 Overview
  • 7.2 Europe Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
  • 7.3 Oncology
    • 7.3.1 Overview
    • 7.3.2 Oncology: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Infectious Disease
    • 7.4.1 Overview
    • 7.4.2 Infectious Disease: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Genetic Testing
    • 7.5.1 Overview
    • 7.5.2 Genetic Testing: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Cardiac Diseases
    • 7.6.1 Overview
    • 7.6.2 Cardiac Diseases: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Immune System Disorders
    • 7.7.1 Overview
    • 7.7.2 Immune System Disorders: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Technology

  • 8.1 Overview
  • 8.2 Europe Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • 8.3 Polymerase Chain Reaction
    • 8.3.1 Overview
    • 8.3.2 PCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.1 RT-PCR
        • 8.3.2.1.1 Overview
    • 8.3.3 RT-PCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.3.1 qPCR
        • 8.3.3.1.1 Overview
    • 8.3.4 qPCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.4.1 Multiplex PCR
        • 8.3.4.1.1 Overview
    • 8.3.5 Multiplex PCR: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.5.1 Others
        • 8.3.5.1.1 Overview
    • 8.3.6 Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 8.4.1 Overview
    • 8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 DNA Sequencing and Next-Generation Sequencing (NGS)
    • 8.5.1 Overview
    • 8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 DNA Microarrays
    • 8.6.1 Overview
    • 8.6.2 DNA Microarrays: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 In-Situ Hybridization (ISH)
    • 8.7.1 Overview
    • 8.7.2 In-Situ Hybridization (ISH): Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

  • 9.1 Overview
  • 9.2 Europe Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • 9.3 Assays and Kits
    • 9.3.1 Overview
    • 9.3.2 Assays and Kits: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Instruments
    • 9.4.1 Overview
    • 9.4.2 Instruments: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Services and Software
    • 9.5.1 Overview
    • 9.5.2 Services and Software: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 - by End User

  • 10.1 Overview
  • 10.2 Europe Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • 10.3 Hospitals and Clinics
    • 10.3.1 Overview
    • 10.3.2 Hospitals and Clinics: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Diagnostics Laboratories
    • 10.4.1 Overview
    • 10.4.2 Diagnostics Laboratories: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Research and Academic Institutes
    • 10.5.1 Overview
    • 10.5.2 Research and Academic Institutes: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: Europe Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Molecular Diagnostics Market - Country Analysis

  • 11.1 Europe Molecular Diagnostics Market, Revenue and Forecast to 2030
    • 11.1.1 Overview
      • 11.1.1.1 Europe Molecular Diagnostics Market by Country
    • 11.1.2 Germany
      • 11.1.2.1 Overview
    • 11.1.3 Germany: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.4 Germany: Molecular Diagnostics Market, by Disease Area
    • 11.1.5 Germany: Molecular Diagnostics Market, by Technology
      • 11.1.5.1 Germany: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.6 Germany: Molecular Diagnostics Market, by Product and Services
    • 11.1.7 Germany: Molecular Diagnostics Market, by End User
    • 11.1.8 UK
      • 11.1.8.1 Overview
    • 11.1.9 UK : Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.10 UK: Molecular Diagnostics Market, by Disease Area
    • 11.1.11 UK: Molecular Diagnostics Market, by Technology
      • 11.1.11.1 UK: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.12 UK: Molecular Diagnostics Market, by Product and Services
    • 11.1.13 UK: Molecular Diagnostics Market, by End User
    • 11.1.14 France
      • 11.1.14.1 Overview
    • 11.1.15 France: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.16 France: Molecular Diagnostics Market, by Disease Area
    • 11.1.17 France: Molecular Diagnostics Market, by Technology
      • 11.1.17.1 France: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.18 France: Molecular Diagnostics Market, by Product and Services
    • 11.1.19 France: Molecular Diagnostics Market, by End User
    • 11.1.20 Italy
      • 11.1.20.1 Overview
    • 11.1.21 Italy: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.22 Italy: Molecular Diagnostics Market, by Disease Area
    • 11.1.23 Italy: Molecular Diagnostics Market, by Technology
      • 11.1.23.1 Italy: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.24 Italy: Molecular Diagnostics Market, by Product and Services
    • 11.1.25 Italy: Molecular Diagnostics Market, by End User
    • 11.1.26 Spain
      • 11.1.26.1 Overview
    • 11.1.27 Spain: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.28 Spain: Molecular Diagnostics Market, by Disease Area
    • 11.1.29 Spain: Molecular Diagnostics Market, by Technology
      • 11.1.29.1 Spain: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
        • 11.1.29.1.1 Spain: Molecular Diagnostics Market, by Product and Services
    • 11.1.30 Spain: Molecular Diagnostics Market, by End User
    • 11.1.31 Rest of Europe
      • 11.1.31.1 Overview
    • 11.1.32 Rest of Europe: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.33 Rest of Europe: Molecular Diagnostics Market, by Disease Area
    • 11.1.34 Rest of Europe: Molecular Diagnostics Market, by Technology
      • 11.1.34.1 Rest of Europe: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.35 Rest of Europe: Molecular Diagnostics Market, by Product and Services
    • 11.1.36 Rest of Europe: Molecular Diagnostics Market, by End User

12. Europe Molecular Diagnostics Market Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Europe Molecular Diagnostics Market, Key Company Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Agilent Technologies Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Thermo Fisher Scientific Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 F. Hoffmann-La Roche Ltd
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Qiagen NV
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 bioMerieux SA
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Illumina Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Danaher
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Siemens Healthineers AG
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Novartis AG
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms